Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Chemotherapy and Radiotherapy
  •  General Oncology
  •  Colorectal Cancer
  •  Chemoprevention
  •  Gastrointestinal Cancer
  •  Kidney Cancer
  •  Sarcomas
  •  Targeted Therapy


Citation: Clin Oncol. 2019;4(1):1635.DOI: 10.25107/2474-1663.1635

Characteristics of Adult Glioblastoma in Kuwait

Anwar Ghanim Al Banaw, Sarah Talib Hussain and Kenneth Chukwuka Katchy

Department of Medical Laboratory Sciences, Kuwait University, KuwaitDepartment of Medical Laboratory, Al-Sabah Hospital, Kuwait

*Correspondance to: Kenneth Chukwuka Katchy 

 PDF  Full Text Research Article | Open Access


Introduction: Classification of Glioblastoma (GBM) into primary (p-GBM) and secondary (s-GBM) is based on IDH1 status. This study aims at evaluating selected biomarkers and clinical characteristics of adult GBM in Kuwait and establishing guidelines for case selection for DNA sequencing. Methods: Archived blocks of 100 GBM initially diagnosed in the Histopathology Unit, AlSabah Hospital between 2009 and 2016 in patients aged ≥ 20 years were retrieved and used for Immunohistochemistry (IHC) for wild-type and mutant IDH1, p53 and EGFR. Patients’ characteristics, presenting symptoms and duration, number of lesions, and tumor anatomic location and extent were extracted from the surgical records. Results: S-GBM comprises 10%, spares patients aged ≥ 60 years, has a mean age of 40.9 years, significant association with young age (<50 years) and an exclusive lobar distribution with a predilection for frontal lobe (60%). P-GBM has a mean age of 50.7 years and a more varied anatomic distribution. In 2%, IHC is negative for both wild-type and mutant IDH1. About 38% and 34% are p53+ and EGFR+. Significantly, 80% of s-GBM and 33% of p-GBM are p53+. EGFR+ is observed in 20% s-GBM and below the age of 35 years. EGFR+ s-GBM is located only in the frontal lobe. EGFR-/p53+, EGFR+-/p53-, EGFR+/p53+, and EGFR-/p53- phenotypes form 27%, 23%, 11% and 39% of all GBM respectively. Symptoms lasted for <3 months in 83%. Only 1% of these have s-GBM. About 13% have multiple lesions. Conclusion: Factors precluding DNA sequencing include patient’s age (≥ 60 years), multiple lesions, short duration of symptoms and EGFR+/p53- phenotype. IHC for wild-type IDH1 is unnecessary for GBM investigation.


Glioblastoma; IDH1; p53; EGFR; Kuwait

Cite the Article:

Al Banaw AG, Hussain ST, Katchy KC. Characteristics of Adult Glioblastoma in Kuwait. Clin Oncol.2019;4:1635 .

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

The Protective Effects of Hepatopoietin Cn (HPPCn) on Acute Liver Injury
 Abstract  PDF  Full Text
Immunohistochemistry Biomarkers in Bladder Cancer: The Old and the New Immunohistochemistry Markers in Bladder Cancer
 Abstract  PDF  Full Text
View More...